ADC THERAPEUTICS

Serial Number 86871984
603

Registration Progress

Application Filed
Jan 11, 2016
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ADC THERAPEUTICS

Basic Information

Serial Number
86871984
Filing Date
January 11, 2016
Abandonment Date
August 1, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
603
Status Date
Aug 1, 2018
Classes
005

Rights Holder

ADC Therapeutics SA

99
Address
Route de la Corniche 3B
Epalinges 1066
CH

Ownership History

ADC Therapeutics SA

Original Applicant
99
Epalinges CH

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description Documents
Aug 3, 2018 MAB3 O ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL Loading...
Aug 1, 2018 EXPT T EXPARTE APPEAL TERMINATED Loading...
Aug 1, 2018 ABN3 O ABANDONMENT - AFTER EX PARTE APPEAL Loading...
Jun 18, 2018 EXFB T EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF Loading...
Apr 2, 2018 CFRC R SUBSEQUENT FINAL REFUSAL WRITTEN Loading...
Apr 2, 2018 GNSF O SUBSEQUENT FINAL EMAILED Loading...
Apr 2, 2018 GNS1 O NOTIFICATION OF SUBSEQUENT FINAL EMAILED Loading...
Mar 6, 2018 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Mar 5, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 27, 2018 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Feb 27, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 27, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 27, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 27, 2018 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Aug 28, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 28, 2017 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 28, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 24, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 24, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 19, 2017 ALIE A ASSIGNED TO LIE Loading...
Jun 13, 2017 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Jun 13, 2017 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Jun 13, 2017 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Jun 13, 2017 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Jun 13, 2017 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Dec 13, 2016 CNFR R FINAL REFUSAL WRITTEN Loading...
Dec 13, 2016 GNFR O FINAL REFUSAL E-MAILED Loading...
Dec 13, 2016 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 3, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 3, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 3, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 3, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 3, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 3, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 26, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 19, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 14, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals for the treatment and prevention of cancer
First Use Anywhere: 20150000
First Use in Commerce: 20150000

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"